Nov 21, 2024 · The use of atogepant 60 mg QD for the preventive treatment of EM and ubrogepant 100 mg PRN for the acute treatment of migraine over the 12-week open-label …

Feb 4, 2023 · Atogepant, an oral calcitonin gene-related peptide (CGRP) receptor antagonist, gained approval as a preventive treatment of episodic migraine in September 2021, while …

Nov 21, 2024 · Some individuals receiving preventive treatment for migraine, such as the oral medication atogepant, may continue to experience migraine attacks and migraine-related …

5 days ago · A phase 4 TANDEM trial in the United States evaluated whether ubrogepant for acute migraine treatment can be safely added to atogepant and used daily for preventive …

A new study supports the safety of combining atogepant and ubrogepant for episodic migraine treatment, offering insights into personalized migraine care and combination therapy.

Jun 23, 2025 · Methods All data of the gepants (rimegepant, atogepant, ubrogepant, and zavegepant) from January 1st 2020 to December 31st 2024 were retrieved from the database. …

Apr 18, 2024 · DENVER — The concomitant use of atogepant for preventive and ubrogepant for acute migraine treatment was found to be safe and well-tolerated over 12 weeks, according to …

Feb 21, 2025 · Conclusion/Interpretation In ubrogepant and atogepant randomized, double-blind, placebo-controlled trials, although analysis power for males is limited due to small sample …

The presented evidence shows the efficacy of rimegepant, ubrogepant, and zavegepant as acute migraine medications as well as atogepant and rimegepant as migraine preventives.

Gepants are unique because they can be used for the treatment of migraine attacks (Ubrogepant, Rimegepant), AND/OR for prevention (Atogepant, Rimegepant). That’s a new reality for …